Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

GlaxoSmithKline

GlaxoSmithKline News Editors

News Widget

Display the GlaxoSmithKline news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

1 hr ago | AmericanBankingNews.com

GlaxoSmithKline's "Buy" Rating Reaffirmed at Societe Generale

's stock had its "buy" rating restated by equities researchers at Societe Generale in a report issued on Thursday, Stock Ratings Network.com reports.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

5 hrs ago | The Standard

GlaxoSmithKline flu jab Pandemrix linked to narcolepsy, study finds...

Finnish researchers unveiled new data to link the Pandemrix flu vaccine made by British drug company GlaxoSmithKline to a higher risk of the sleeping disorder narcolepsy in adults.

Comment?

Related Topix: Narcolepsy, Medicine, Health, Vaccinations, Biotech, GlaxoSmithKline, Healthcare Industry, Influenza, H1N1 Influenza / Swine Flu

7 hrs ago | Pharmaceutical Technology

US Government Signs Deal with GSK to Develop Antibiotics

GlaxoSmithKline and the Biomedical Advanced Research and Development Authority , part of the United States Department of Health and Human Services , have agreed to a collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism, GSK announced in a press release .

Comment?

Related Topix: Biotech

11 hrs ago | Forbes.com

Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings

This post was written by Steven E. Nissen MD, the Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic.

Comment?

Related Topix: Healthcare Law, Law, Avandia, Rosiglitazone (generic), Medicine, Prison, Biotech, Healthcare Industry

15 hrs ago | BioSpace

GlaxoSmithKline Flu Shot May Raise Adult Narcolepsy Risk

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday.

Comment?

Related Topix: Narcolepsy, Medicine, Biotech, H1N1 Influenza / Swine Flu, Vaccinations

18 hrs ago | The New Zealand Herald

NZ running low on chickenpox vaccines

New Zealand is running low on chickenpox vaccines as more parents seek to have their children immunised and as winter approaches.

Comment?

Related Topix: Chickenpox, Health, Vaccinations, Biotech, Family, Kids, Parenting

23 hrs ago | The Press On-Line

Chickenpox vaccine supplies run out

Drug company GlaxoSmithKline has notified medical centres throughout the country that the Varilrix vaccine would be temporarily out of stock for the next few weeks.

Comment?

Related Topix: Chickenpox, Health, Biotech

Wed May 22, 2013

AmericanBankingNews.com

GlaxoSmithKline Stock Rating Reaffirmed by BNP Paribas

's stock had its "underperform" rating restated by analysts at BNP Paribas in a research report issued to clients and investors on Wednesday, ARN reports.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Drug Researcher

Aspen & Local CMOs to Benefit from GSK's Aus Packaging Plant Closure

GlaxoSmithKline says some manufacturing from the shuttering of an Australian packaging site will be picked up by Aspen and local third-party contractors.

Comment?

Related Topix: Biotech, Outsourcing

BioSpace

GlaxoSmithKline Says Lowering Prices in China Caused Higher Sales

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! by Richard Daverman, PhD May 21, 2013 -- Want to increase revenues in China? You might try lowering prices.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

NEWS.com.au

GlaxoSmithKline axes 120 jobs

Olivia Walker and Rod Ashton working on the Ventolin production line at GlaxoSmithKline pharmaceutical plant at Boronia.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Reuters

U.S. government taps GlaxoSmithKline for new antibiotics

The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry, Centers for Disease Control and Prevention

Tue May 21, 2013

The Motley Fool

What Are the City's Expectations for GlaxoSmithKline's Profits?

When weighing a potential investment, it's useful to look forward rather than backwards.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Mon May 20, 2013

AmericanBankingNews.com

GlaxoSmithKline Receives Buy Rating from Cenkos Securities Ltd

's stock had its "buy" rating reaffirmed by Cenkos Securities Ltd in a research note issued on Monday, Analyst Ratings Network reports.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Thu May 16, 2013

Daily Mail

Market Report: GlaxoSmithKline tipped for Danish drug deal

Ever since GSK in December 2006 broke a then industry record by licensing a drug for leukaemia from Genmab for 1.6bn, taking a 10 per cent stake in the process, the pharmaceutical world has expected GSK to one day launch a full-scale cash offer.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry, Food and Drug Administration

Express India

MSCI India adds Wockhardt, OIL, GSK Consumer, Apollo Hospitals

Apollo Hospitals, Oil India, Wockhardt and GlaxoSmithKline Consumer Healthcare have been added to the MSCI India index.

Comment?

Related Topix: Biotech

Wed May 15, 2013

Pharmaceutical Technology

Theravance and Elan Enter $1 Billion Royalty Participation Agreement

Theravance and Elan announced in a press release that Elan will purchase a participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline : RELVAR ELLIPTA/BREO ELLIPTA , ANORO ELLIPTA , MABA monotherapy , and vilanterol monotherapy.

Comment?

Related Topix: Theravance, Startups, Biotech

Fortune

Dirty medicine

On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, World News, India, Asia Travel, Delhi, India Travel, India Travel, Travel, GlaxoSmithKline, Medicine, Healthcare Industry

Tue May 14, 2013

Freshnews

OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of...

OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today announced clinical progress with its Anti-Notch2/3 product candidate, which will trigger an $8 million milestone payment from the company's strategic collaborator GlaxoSmithKline .

Comment?

Related Topix: Startups, OncoMed Pharmaceuticals, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Oncology, Health, Lung Cancer, Pancreatic Cancer

AmericanBankingNews.com

GlaxoSmithKline's "Buy" Rating Reaffirmed at TheStreet

's stock had its "buy" rating reiterated by equities research analysts at TheStreet in a research note issued to investors on Tuesday, AnalystRatingsNetwork reports.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Ashburn Jobs